Body Handbook Catalogue Profile Ranking
Psychology BODY HANDBOOK
Psychology ยท ยง469
Microdosing Psilocybin and LSD
Microdosing takes a tenth of a recreational dose of LSD or psilocybin on a schedule, for a low-key lift to mood, focus, and creativity without a trip. The pharmacology is real: even a dose you can't feel raises BDNF and hits the same receptor a full dose does Hutten 2020. The felt lift is what fails. Four blinded trials found real microdoses improved people exactly as much as placebos they believed were real Szigeti 2021. For most, it is an expensive, illegal ritual.
Do ยท Course Evidence Mixed Chapter Psychology

The surveys and the trials tell opposite stories. Diary-keepers who chose to microdose report better mood, focus, and calm 1 โ€” but that self-selecting group is a placebo machine, not a test of the drug. Blind them and it vanishes: when microdosers mixed real capsules with placebos, mood, depression, and anxiety improved equally in both arms 2. Controlled lab trials found no effect on memory or cognition, and creativity that ran slower 345. The 2024 review of every blinded study agreed 6.

One signal survives. People with existing depression felt more from a low LSD dose than from placebo, and scored lower 48 hours later 7 โ€” one subgroup, one study, but the only blinded hint of something real. If you have mild-to-moderate depression, this is genuinely unsettled; if you don't, it isn't.

If you try it anyway, run it as a defined test with an end date, comparing dose days against off days.

Calibration is the trap: mushrooms vary tenfold in potency between batches, so a volumetric LSD tincture is the only reliably measured form.

How the six weeks tend to go. Day one brings a faint warmth and a mood most call "a good day, deliberately" โ€” exactly what placebo days produce 2. By week three the dose-day effect dims as tolerance builds 3. At the end, most feel a little better off but can't say how much was the drug versus the attention.

The problems it claims to fix have better-evidenced, legal answers: an SSRI plus CBT for depression (or licensed full-dose psilocybin therapy), CBT and exercise for anxiety, an ADHD diagnosis and a prescriber for attention. For creative block, blinded microdose data is null or negative 3.

The legal reality most guides skip: in 2026, possessing LSD or psilocybin is a federal felony almost everywhere, at any dose 11. Colorado is the one clean personal-use safe harbour, having decriminalized possession and home cultivation for adults 21+ 12. City "deprioritization" votes only lower police priority.

The fine print โ€” when to skip it, and what people get wrong

Skip it with valvular or structural heart disease: psychedelics bind the receptor whose chronic activation caused fenfluramine's valve damage 910. Also skip with an SSRI, MAOI, lithium, or a psychosis or bipolar I history.

"Sub-perceptual means safe" is wrong: you can't feel the receptor activity, which is the point of the fenfluramine comparison. "The community knows it works" describes a self-selected placebo machine, never a control group.

References
  1. 1Anderson T, Petranker R, Christopher A, Rosenbaum D, Weissman C, Dinh-Williams LA, Hui K, Hapke E (2019). Psychedelic microdosing benefits and challenges: an empirical codebook. Harm Reduction Journal. link
  2. 2Szigeti B, Kartner L, Blemings A, Rosas F, Feilding A, Nutt DJ, Carhart-Harris RL, Erritzoe D (2021). Self-blinding citizen science to explore psychedelic microdosing. eLife. link
  3. 3de Wit H, Molla HM, Bershad A, Bremmer M, Lee R (2022). Repeated low doses of LSD in healthy adults: A placebo-controlled, dose-response study. Addiction Biology. link
  4. 4Cavanna F, Muller S, de la Fuente LA, Zamberlan F, Palmucci M, Janeckova L, Kuchar M, Pallavicini C, Tagliazucchi E (2022). Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study. Translational Psychiatry. link
  5. 5Marschall J, Fejer G, Lempe P, Prochazkova L, Kuchar M, Hajkova K, van Elk M (2022). Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study. Journal of Psychopharmacology. link
  6. 6Polito V, Liknaitzky P (2024). Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research. Journal of Psychopharmacology. link
  7. 7Molla H, Lee R, Tare I, de Wit H (2024). Greater subjective effects of a low dose of LSD in participants with depressed mood. Neuropsychopharmacology. link
  8. 8Fadiman J (2011). The Psychedelic Explorer's Guide: Safe, Therapeutic, and Sacred Journeys. link
  9. 9Tagen M, Mantuani D, van Heerden L, Holstein A, Klumpers LE, Knowles R (2023). The risk of chronic psychedelic and MDMA microdosing for valvular heart disease. Journal of Psychopharmacology. link
  10. 10Rouaud A, Calder AE, Hasler G (2024). Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins. Journal of Psychopharmacology. link
  11. 11DEA (2024). Drug Scheduling: Schedule I Controlled Substances (Psilocybin, LSD). link
  12. 12Colorado General Assembly (2022). Proposition 122: Natural Medicine Health Act. link
Related in the handbook (3)
Alternatives
  • โ€” If you want the altered state without a substance, holotropic breathwork chases the same territory through breath.
Related
  • โ€” Unlike microdosing, ketamine actually beats placebo for depression โ€” a useful contrast in what 'psychedelic medicine' has proven.
  • โ€” The focus-and-creativity promise is the same one nootropics make โ€” and microdosing fails it in blinded trials.
ยท
469